CANCER TREATMENT CENTERS OF AMERICA RECEIVES 2021 PRESS GANEY GUARDIAN OF EXCELLENCE AWARD®

Article
City of Hope

Comprehensive cancer centers in Chicago and Atlanta earn national distinction as top performers in patient experience.

Boca Raton, Fla., December 16, 2021, Cancer Treatment Centers of America® (CTCA) is pleased to announce its hospitals in Atlanta and Chicago have been named 2021 Guardian of Excellence Award® winners by Press Ganey, the national leader in healthcare consumer and workforce engagement. Press Ganey recognizes CTCA® as a top-performing healthcare organization, with its hospital in Georgia being one of two in the state and its hospital in Illinois being one of five in the state, that achieved the 95th percentile or above for performance in patient experience.

The Press Ganey Guardian of Excellence Award® is a preeminent, competitive achievement for leading healthcare organizations. Presented annually, the award applauds hospitals and health systems that consistently sustained performance in the top 5% of all Press Ganey clients.

“Press Ganey is honored to recognize multiple CTCA hospitals among the nation’s leaders in patient experience,” said Patrick T. Ryan, chairman and chief executive officer, Press Ganey. “This award reflects an unwavering commitment to earn the trust and loyalty of patients throughout unimaginable challenges. We are humbled by CTCA’s incredible efforts, and their ability to adapt to imperatives of COVID-19 on top of the increasing demand for consumerism in healthcare.”

The CTCA Atlanta and Chicago teams initiated a number of best practices, which were instrumental in the hospitals achieving consistently sustained performance within the top five percent of all Press Ganey clients in the category of patient experience based on inpatient HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) survey results. These initiatives included monthly patient satisfaction meetings to review patient comments and develop action plans to address opportunities for improvement. Additionally, the teams implemented a cadence of follow up phone calls from leadership with patients and caregivers to address survey comments, utilization of technology to improve patient communication and engagement, hourly rounding by nursing staff and daily leader rounding, which allowed for real-time issue resolution and enhanced communication between departments.

“This recognition reflects our dedication to not only delivering highly skilled patient-centered oncology care across the cancer care continuum, but also the commitment of our employees who worked tirelessly throughout a chaotic year to positively impact the lives of everyone we serve,” said Pat Basu, MD, MBA, President and CEO of CTCA. Dr. Basu further explained that Press Ganey’s Guardian of Excellence Award® demonstrates that the Atlanta and Chicago communities can receive top-rated care close to home.

About Press Ganey

Press Ganey pioneered the health care performance improvement movement 35 years ago. Today Press Ganey offers an integrated suite of solutions that enable enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform built on a foundation of data security, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement. The company works with more than 41,000 health care facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality, and experience of care.

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA®publishes treatment results bi-annually including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.

Media Contact:

Cancer Treatment Centers of America

Samantha Paz

samantha.paz@ctca-hope.com
215-537-7080

Press Ganey

Sarah Adell, Director of Communications

815.499.5122

Sarah.Adell@PressGaney.com

Related Videos
Cancer vaccines are a “cross-cutting approach” that may be applicable across several cancer types, according to Catherine J. Wu, MD.
mRNA may be a potential modality for developing cancer-based vaccines, according to Catherine J. Wu, MD.
Analyzing the KRAS mutation across various cancer types may be a worthwhile target when using a cancer vaccine or immunotherapy, says Catherine J. Wu, MD.
The AACR Health Disparities Report highlights the changes needed to achieve health equity for patients with cancer.
Robert A. Winn, MD, gives insight into how institutions and community practices can improve access to cancer care.
In the October edition of Snap Recap, we review the latest FDA news and the vote from the last ODAC meeting.
In this September edition of Snap Recap, we share our highlights from Prostate Cancer Awareness Month, news in the breast cancer space, and the latest FDA updates.
Implementing tax benefits for manufacturers who produce chemotherapy drugs may be one solution to increase drug production in the United States, according to Lucio N. Gordan, MD.
Lucio N. Gordan, MD, describes how his practice deals with increasing costs of limited chemotherapy agents to ensure that patients with cancer continue to receive treatment.